Английская Википедия:BMY-14802

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

BMY-14802, also known as BMS-181100, is a drug with antipsychotic effects which acts as both a sigma receptor antagonist and a 5-HT1A receptor agonist.[1][2][3][4] It also has affinity for the 5-HT2 and D4 receptors.[5] The drug reached phase III clinical trials for the treatment of psychosis but was never marketed.[6]

See also

References

Шаблон:Reflist

Шаблон:Dopamine receptor modulators Шаблон:Serotonin receptor modulators Шаблон:Sigma receptor modulators

Шаблон:Nervous-system-drug-stub